Related Experiment Video
Updated: Nov 28, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
[Clinical analysis of 14 infective endocarditis in patients with obstructive hypertrophic cardiomyopathy]
1Cardiac Arrhythmia Center, Fuwai Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, State Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Beijing 100037, China.
Insights
Infective endocarditis (IE) in hypertrophic cardiomyopathy (HCM) patients is rare but serious. Early cardiac surgery is recommended for better outcomes in these complex cases.
Area of Science:
- Cardiology
- Infectious Diseases
Background:
- Hypertrophic cardiomyopathy (HCM) is a genetic heart condition.
- Infective endocarditis (IE) is a serious infection of the heart lining.
- The co-occurrence of IE and HCM presents unique clinical challenges.
Purpose of the Study:
- To analyze the clinical characteristics of patients with both infective endocarditis and hypertrophic cardiomyopathy.
- To understand the specific manifestations, pathogens, and outcomes in this patient cohort.
Main Methods:
- Retrospective analysis of 14 patients diagnosed with both HCM and IE.
- Data collected included clinical manifestations, blood cultures, echocardiography, treatment, and outcomes.
- Comparison with general IE and HCM populations where applicable.
Main Results:
- IE in HCM patients occurred in 0.19% of HCM cases.
- Common symptoms included fever and heart murmur; heart failure and embolism were frequent complications.
- Echocardiography revealed vegetation in all patients, often on the mitral valve, with severe left ventricular outflow obstruction.
- Gram-positive cocci, primarily Streptococcus, were the main pathogens.
Conclusions:
- IE is a rare but significant complication in HCM patients.
- Septic embolization and valve lesions are prevalent, suggesting a poorer prognosis.
- Early cardiac surgery intervention is crucial for improving survival rates in these patients.
Abstract:
Objective: This observational study was aimed to analyze the clinical characteristics of infective endocarditis (IE) in patients with hypertrophic cardiomyopathy (HCM). Methods: A total of 668 patients with IE, and 7 427 patients with HCM were treated in Fuwai Hospital from August 2006 to December 2018. Among them, 14 patients were diagnosed with HCM and IE. The clinical characteristics of these patients including clinical manifestations, pathogen distribution, echocardiography features, in-hospital treatment and outcomes were analyzed retrospectively. Results: The proportion of HCM patients with IE was 0.19%,with the estimated incidence of 0.15/1 000 person-years in HCM patients. Of the 14 patients, 11 patients were male. The most common clinical manifestations were fever and heart murmur, and the main complications were heart failure (12/14) and bacterial embolism (8/14). There were 8 cases (8/14) with positive blood culture, and all causative bacteria were gram positive coccus, in which 5/8 were Streptococcus. The median interventricular septum thickness was (21.2±2.7) mm, and left ventricular outflow obstruction was severe based on echocardiography (Echo) examination. The Echo showed that vegetation was found in all 14 patients and most of the vegetation attached at the anterior leaflet of mitral valve (12/14). The proportions of patients with circulatory embolism (8/14) and valve lesions (12/14) were relatively high. Most cases (10/14) were cured, especially those underwent cardiac surgery (8 cases). The rest 4 cases died with 2 in hospital and 2 after auto-discharge. Conclusions: HCM patients complicated with IE are rare. Septic embolization and valve lesions are common in these patients. IE patients with HCM might have a poor prognosis compared to those without HCM and should receive cardiac surgery as early as possible.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Endocarditis II: Clinical Features of Infective Endocarditis
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

